An independent, evidence-based review of Emerge, a cash-pay GLP-1 telehealth platform. Covers business model, prescribing practices, cost structure, clinical backing, and how Emerge compares to competitors.
Independent analysis of Emerge telehealth's safety record, regulatory compliance, prescribing practices, and how it compares to other GLP-1 telehealth platforms.
An independent clinical assessment of Emerge, the cash-pay GLP-1 telehealth service. Learn who benefits most, how it compares to alternatives, what it prescribes, costs, and whether it is worth it.
Help Pharmacy is an FDA-registered 503B facility licensed in all 50 states, with Form 483 observations on record. See its full inspection and compliance history.
An evidence-based comparison of Evernow alternatives for perimenopause and menopause care, including HRT telehealth platforms, non-hormonal options, and specialized providers for each symptom profile.
An independent clinical review of Evernow's online prescription and intake process for menopause and perimenopause hormone therapy, including how it compares to alternatives.
Independent pricing breakdown of Evernow's telehealth menopause platform, including consultation fees, medication costs, and how total spend compares to alternatives like Midi Health and traditional HRT clinics.
An independent, citation-backed analysis of Evernow's safety record, regulatory compliance, prescribing practices, and how it compares to alternatives for perimenopause and menopause care.
An independent, evidence-based review of Evernow's clinical gaps, formulary limitations, and care-model shortcomings for perimenopause and menopause treatment.
An independent, evidence-based look at who benefits most from Evernow's menopause telehealth platform, what it prescribes, how much it costs, and how it compares to alternatives.
An independent comparison of Function Health against lab-testing alternatives for longevity, hormones, metabolic health, and budget-conscious panels.
Is Function Health legit? We examine Function Health's safety record, regulatory compliance, lab certifications, and how it compares to alternatives in the direct-to-consumer lab testing space.
An independent, evidence-based review of Gennev's menopause telehealth platform, including its clinical model, pricing, prescribing scope, and how it compares to alternatives.
An evidence-based assessment of Gennev's safety practices, regulatory compliance, prescribing standards, and how its menopause telehealth model compares to clinical guidelines.
An evidence-based comparison of Hallandale Pharmacy alternatives for compounded hormones, peptides, and weight-loss medications, with clinical citations and use-case recommendations.
Independent analysis of Hallandale Pharmacy's regulatory status, compounding standards, accreditation, and safety track record for compounded peptides, HRT, and other formulations.
An independent clinical analysis of Hallandale Pharmacy's compounded peptides, HRT, and TRT offerings, including what their model misses and where alternatives may serve patients better.
An evidence-based comparison of Happy Head alternatives for hair loss, including FDA-approved treatments, compounding pharmacies, and telehealth platforms ranked by use case.
Independent pricing breakdown of Happy Head compounded hair loss treatments. We compare subscription costs, ingredient value, and alternatives with clinical evidence.
Independent analysis of Henry Meds compounded semaglutide and tirzepatide outcomes, pricing, legitimacy, and how the platform compares to alternatives. prepared by the HealthRX.com Editorial Team.
An independent clinical review of how Hers handles prescriptions, from the online intake questionnaire through provider review and medication delivery, with evidence-based analysis of its telehealth model.
An independent pricing analysis of Hims telehealth subscriptions for ED, hair loss, HRT, and mental health. Includes per-month costs, hidden fees, and comparisons to alternatives.
An independent clinical analysis of Hims telehealth platform gaps, including limited lab monitoring, narrow formulary depth, and protocol shortcomings compared to specialist-led hormone therapy.
An independent, evidence-based comparison of InsideTracker alternatives for blood biomarker testing, DNA analysis, and lifestyle optimization, organized by use case and budget.
A critical, evidence-based review of InsideTracker's blood-biomarker, DNA, and lifestyle platform. Learn what the intake process involves, what InsideTracker actually prescribes, costs, and how it compares to alternatives.
Independent pricing breakdown of InsideTracker plans, add-ons, and hidden costs. We compare per-biomarker value against competitors and evaluate whether the subscription model delivers clinical utility worth the price.
An independent, evidence-based analysis of InsideTracker blood, DNA, and lifestyle testing. We examine published research, real user outcomes, and how the platform compares to alternatives.
An independent, citation-backed analysis of InsideTracker's clinical gaps, including missing biomarkers, absence of prescriptive authority, reference-range concerns, and how the platform compares to physician-led care.
Independent analysis of Juniper's women-focused GLP-1 and nutrition telehealth program. We examine clinical evidence, real-world outcome expectations, cost, and how the model compares to alternatives.
Independent analysis of Juniper's safety record, regulatory compliance, prescribing practices, and how the women-focused GLP-1 telehealth platform compares to alternatives.
Keeps is a legitimate telehealth service prescribing FDA-approved finasteride and minoxidil for hair loss, costing $25-75/month via asynchronous doctor visits.
An independent clinical review of the Keeps telehealth prescription process for men's hair loss, including what drugs are offered, how the intake works, costs, and how Keeps compares to alternatives.
Independent pricing breakdown of Keeps hair loss subscriptions, including per-month costs for finasteride and minoxidil, how Keeps compares to retail pharmacy pricing and competitor telehealth platforms, and whether the subscription model saves money.
Independent analysis of Keeps telehealth platform for men's hair loss, covering FDA-approved medications, regulatory compliance, prescription practices, and how it compares to alternatives.
An evidence-based analysis of which men benefit most from Keeps hair loss treatments, including finasteride and minoxidil candidacy, limitations, and how the platform compares to alternatives.
An independent, evidence-based comparison of Levels CGM alternatives for metabolic health, weight management, athletic performance, and budget-friendly glucose tracking.
Levels costs $199 a year plus CGM sensors, totaling roughly $399 to $599 in year one. See membership fees, sensor prices, and what's not included.
An independent, evidence-based analysis of Levels CGM-driven metabolic health platform, examining real customer outcomes against published clinical data on continuous glucose monitoring.
An evidence-based analysis of who benefits most from Levels CGM-driven metabolic health monitoring, including ideal patient profiles, cost breakdown, and clinical evidence for continuous glucose monitoring.
An independent clinical assessment of Life Extension's supplement and Rx longevity platform, including who benefits most, cost analysis, evidence review, and how it compares to alternatives.
Independent comparison of Limitless Life peptide and NAD+ protocols against clinically backed alternatives for weight loss, anti-aging, cognitive support, and recovery.
Marek Health is a cash-pay TRT and peptide telehealth service from $250-$350 per visit. Independent review of its model, pricing, and evidence base.
Independent analysis of Marek Health's TRT, peptide, and lab-optimization services. Real patient outcomes weighed against published clinical evidence and competitor alternatives.
Independent analysis of Marek Health's safety record, regulatory compliance, prescribing practices, and how it compares to alternatives in the TRT and peptide telehealth space.
An independent, evidence-based analysis of Marek Health's clinical gaps, including TRT monitoring blind spots, peptide oversight, and lab optimization limitations.
A clinical breakdown of the Midi Health intake process, prescription options for perimenopause and menopause, cost structure, and how it compares to alternatives.
Independent pricing analysis of Midi Health for perimenopause and menopause care. We break down consultation fees, medication costs, insurance coverage, and how Midi compares to alternatives.
An independent assessment of Midi Health's safety record, regulatory compliance, telehealth prescribing framework, and how its menopause care model aligns with current clinical guidelines.
Independent analysis of Mochi Health's telehealth GLP-1 weight loss platform, including pricing, prescribing practices, insurance coverage, and how it compares to competitors.
An evidence-based analysis of who benefits most from Mochi Health's GLP-1 weight loss program, including ideal patient criteria, clinical eligibility, cost considerations, and how it compares to alternatives.
An independent, evidence-based comparison of Momentous supplements with clinically validated alternatives for creatine, protein, omega-3, sleep, and collagen.
Compare Musely alternatives by treatment goal, exact formulation, current service availability, consultation fees and the full billed cost.
Independent pricing breakdown of Musely's prescription skincare and anti-aging treatments. We compare costs, analyze hidden fees, and evaluate whether the D2C telehealth model delivers clinical value for the price.
An independent clinical analysis of Musely's telehealth dermatology platform, examining gaps in evidence, compounding concerns, and limitations of its asynchronous care model for women's aesthetics.
Noom subscription costs $17 to $70 monthly for coaching, or $209 yearly. Adding Noom Med runs $149 more, pushing totals past $6,000 with GLP-1s.
Independent analysis of Noom's safety record, regulatory compliance, clinical evidence, and how its GLP-1 prescribing program compares to telehealth alternatives.
Nurx business model: asynchronous, direct-to-consumer telehealth across four verticals (birth control, PrEP, dermatology, HRT) with $15-$75 consult fees.
Independent analysis of Nurx telehealth outcomes for birth control, skin care, and HRT prescriptions, with cited clinical evidence and patient satisfaction data.
Independent analysis of Nurx's safety record, regulatory compliance, prescribing practices, and how the telehealth platform compares to alternatives for birth control, HRT, and dermatology.
Independent breakdown of Nutrisense CGM subscription costs, hidden fees, coaching tiers, and how pricing compares to alternatives like Levels and Signos.